Patient Square Capital Announces the Formation of Enavate Sciences to Invest in and Support Therapeutic Companies
- Monday, May 2, 2022, 7:03
- Finance
- Add a comment
James Boylan, Accomplished Health Care Executive, Joins Enavate as CEO $300 Million Initial Investment Commitment Received MENLO PARK, Calif., May 2, 2022 /PRNewswire/ — Patient Square Capital (“Patient Square”), a leading dedicated health care investment firm, today announced the…
About the Author
adminasapcorp has written 38955 stories on this site.